Valuation Indivior Pharmaceuticals, Inc. London S.E.

Stocks

Market Closed - London S.E. 18:35:04 24/07/2025 +03			5-day change	1st Jan Change
1,238.00 ^GBX	+1.56%		+5.27%	+20.90%

08-03	Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility	CI
08-03	Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	4,245	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	-5.24%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	4,232	3,675	3,054
Change	-	55.81%	-17.52%	-21.95%	193.72%	-8.07%	-13.17%	-16.89%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	9.67x	8.76x	8.01x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.8x	0.85x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3.19x	3.03x	2.85x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	3.18x	2.63x	2.05x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.81x	4.65x	3.55x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	6.14x	4.98x	3.84x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	8.31x	6.75x	4.94x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	12%	14.8%	20.2%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,332	1,400	1,489
EBITDA ¹	202	225	288	338	428	728.4	790.8	859.6
EBIT ¹	187	212	269	312	415	688.8	737.7	795.7
Net income ¹	205	-53	2	-48	210	474.3	530	582.9
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	35.97	35.97	35.97
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	2/16/22 A	2/16/23 A	2/22/24 A	2/20/25 A	2/26/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	35.12x	12.73x	25.81x	0.56%	1,100B
JOHNSON & JOHNSON	30.38x	-	-	1.97%	658B
ABBVIE INC.	33.92x	7.84x	16.3x	2.58%	470B
ROCHE HOLDING AG	20.83x	4.94x	12.23x	2.67%	372B
NOVARTIS AG	22.71x	5.84x	14.47x	2.73%	304B
ASTRAZENECA PLC	21.88x	4.48x	12.79x	1.96%	264B
AMGEN INC.	27.97x	7.21x	12.8x	2.28%	239B
NOVO NORDISK A/S	13.99x	4.96x	10.35x	3.67%	213B
GILEAD SCIENCES, INC.	-45.46x	6.56x	25.6x	2.22%	184B
Average	17.93x	6.82x	16.29x	2.29%	422.54B
Weighted average by Cap.	25.31x	8.41x	18.55x	1.89%